Cargando…

雷帕霉素对重型再生障碍性贫血模型小鼠脾脏CD4(+)CD25(+) T细胞凋亡的影响

OBJECTIVE: To explore the effects and possible mechanism of rapamycin (RAPA) on apoptosis of CD4(+)CD25(+) Tregs from the mouse severe aplastic anemia (SAA) model. METHODS: The BALB/c female SAA model mice were induced by interferon-gamma in combination with busulphan. The SAA model mice were intrap...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342986/
https://www.ncbi.nlm.nih.gov/pubmed/29562463
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.03.005
_version_ 1783555658235248640
collection PubMed
description OBJECTIVE: To explore the effects and possible mechanism of rapamycin (RAPA) on apoptosis of CD4(+)CD25(+) Tregs from the mouse severe aplastic anemia (SAA) model. METHODS: The BALB/c female SAA model mice were induced by interferon-gamma in combination with busulphan. The SAA model mice were intraperitoneal injection with RAPA at daily dose of 0.5 mg/kg for 5 days (the RAPA-treated group, n=15) in the SAA group (n=15) and the un-treated group (n=15) were control. Bone marrow hematopoiesis changes were observed by the patho-morphological examination of femurs. The mononuclear cells of the peripheral blood and spleen were subjected to assess the intracellular Foxp3 expression in CD4(+)CD25(+) Tregs by flow cytometry (FCM). In addition, after being pured by immunomagnetic beads, the splenic CD4(+)CD25(+) Tregs was subjected to assess apoptosis by FCM and the Akt and Stat3 phosphorylation by using of western blot. RESULTS: The patho-morphological examination of femurs showed normal marrow cell proliferation in un-treated group and hypocellularity in both SAA group and RAPA-treat group, with an increase in the number of fat cells. The bone marrow hematopoietic tissue ratio in RAPA-treat group was higher than SAA group [(9.75±1.83)% vs (7.00±2.00)%, Δx=2.15% (95%CI 0.15%–5.35%), P=0.037]. In the SAA group, FCM analysis showed down-expression of Foxp3 in CD4(+)CD25(+) Tregs compared with the un-treated group. However, after treatment with RAPA, the expression of Foxp3 in CD4(+)CD25(+) Tregs was increased (P<0.017). Compared with the un-treated group, increased CD4(+)CD25(+) Tregs apoptosis [(19.84±1.39)% vs (29.85±2.72)%] with increased Akt phosphorylation accompanied by increased Stat3 phosphorylation was found in SAA group (P<0.05, respectively). On the contrary, RAPA-treated group exhibited CD4(+) CD25(+) Tregs with a reduction in apoptosis rate [(22.39±3.71)%], Akt phosphorylation and Stat3 phosphorylation compared with the SAA group (P<0.05, respectively). CONCLUSION: These results indicate that RAPA may increase the expression of Foxp3 by down-regulation the levels of Akt and Stat3 phosphorylation and reduce apoptosis in splenic CD4(+)CD25(+) Tregs from the mice model of SAA.
format Online
Article
Text
id pubmed-7342986
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Editorial office of Chinese Journal of Hematology
record_format MEDLINE/PubMed
spelling pubmed-73429862020-07-16 雷帕霉素对重型再生障碍性贫血模型小鼠脾脏CD4(+)CD25(+) T细胞凋亡的影响 Zhonghua Xue Ye Xue Za Zhi 论著 OBJECTIVE: To explore the effects and possible mechanism of rapamycin (RAPA) on apoptosis of CD4(+)CD25(+) Tregs from the mouse severe aplastic anemia (SAA) model. METHODS: The BALB/c female SAA model mice were induced by interferon-gamma in combination with busulphan. The SAA model mice were intraperitoneal injection with RAPA at daily dose of 0.5 mg/kg for 5 days (the RAPA-treated group, n=15) in the SAA group (n=15) and the un-treated group (n=15) were control. Bone marrow hematopoiesis changes were observed by the patho-morphological examination of femurs. The mononuclear cells of the peripheral blood and spleen were subjected to assess the intracellular Foxp3 expression in CD4(+)CD25(+) Tregs by flow cytometry (FCM). In addition, after being pured by immunomagnetic beads, the splenic CD4(+)CD25(+) Tregs was subjected to assess apoptosis by FCM and the Akt and Stat3 phosphorylation by using of western blot. RESULTS: The patho-morphological examination of femurs showed normal marrow cell proliferation in un-treated group and hypocellularity in both SAA group and RAPA-treat group, with an increase in the number of fat cells. The bone marrow hematopoietic tissue ratio in RAPA-treat group was higher than SAA group [(9.75±1.83)% vs (7.00±2.00)%, Δx=2.15% (95%CI 0.15%–5.35%), P=0.037]. In the SAA group, FCM analysis showed down-expression of Foxp3 in CD4(+)CD25(+) Tregs compared with the un-treated group. However, after treatment with RAPA, the expression of Foxp3 in CD4(+)CD25(+) Tregs was increased (P<0.017). Compared with the un-treated group, increased CD4(+)CD25(+) Tregs apoptosis [(19.84±1.39)% vs (29.85±2.72)%] with increased Akt phosphorylation accompanied by increased Stat3 phosphorylation was found in SAA group (P<0.05, respectively). On the contrary, RAPA-treated group exhibited CD4(+) CD25(+) Tregs with a reduction in apoptosis rate [(22.39±3.71)%], Akt phosphorylation and Stat3 phosphorylation compared with the SAA group (P<0.05, respectively). CONCLUSION: These results indicate that RAPA may increase the expression of Foxp3 by down-regulation the levels of Akt and Stat3 phosphorylation and reduce apoptosis in splenic CD4(+)CD25(+) Tregs from the mice model of SAA. Editorial office of Chinese Journal of Hematology 2018-03 /pmc/articles/PMC7342986/ /pubmed/29562463 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.03.005 Text en 2018年版权归中华医学会所有 http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal.
spellingShingle 论著
雷帕霉素对重型再生障碍性贫血模型小鼠脾脏CD4(+)CD25(+) T细胞凋亡的影响
title 雷帕霉素对重型再生障碍性贫血模型小鼠脾脏CD4(+)CD25(+) T细胞凋亡的影响
title_full 雷帕霉素对重型再生障碍性贫血模型小鼠脾脏CD4(+)CD25(+) T细胞凋亡的影响
title_fullStr 雷帕霉素对重型再生障碍性贫血模型小鼠脾脏CD4(+)CD25(+) T细胞凋亡的影响
title_full_unstemmed 雷帕霉素对重型再生障碍性贫血模型小鼠脾脏CD4(+)CD25(+) T细胞凋亡的影响
title_short 雷帕霉素对重型再生障碍性贫血模型小鼠脾脏CD4(+)CD25(+) T细胞凋亡的影响
title_sort 雷帕霉素对重型再生障碍性贫血模型小鼠脾脏cd4(+)cd25(+) t细胞凋亡的影响
topic 论著
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342986/
https://www.ncbi.nlm.nih.gov/pubmed/29562463
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.03.005
work_keys_str_mv AT léipàméisùduìzhòngxíngzàishēngzhàngàixìngpínxuèmóxíngxiǎoshǔpízàngcd4cd25txìbāodiāowángdeyǐngxiǎng
AT léipàméisùduìzhòngxíngzàishēngzhàngàixìngpínxuèmóxíngxiǎoshǔpízàngcd4cd25txìbāodiāowángdeyǐngxiǎng
AT léipàméisùduìzhòngxíngzàishēngzhàngàixìngpínxuèmóxíngxiǎoshǔpízàngcd4cd25txìbāodiāowángdeyǐngxiǎng
AT léipàméisùduìzhòngxíngzàishēngzhàngàixìngpínxuèmóxíngxiǎoshǔpízàngcd4cd25txìbāodiāowángdeyǐngxiǎng
AT léipàméisùduìzhòngxíngzàishēngzhàngàixìngpínxuèmóxíngxiǎoshǔpízàngcd4cd25txìbāodiāowángdeyǐngxiǎng
AT léipàméisùduìzhòngxíngzàishēngzhàngàixìngpínxuèmóxíngxiǎoshǔpízàngcd4cd25txìbāodiāowángdeyǐngxiǎng
AT léipàméisùduìzhòngxíngzàishēngzhàngàixìngpínxuèmóxíngxiǎoshǔpízàngcd4cd25txìbāodiāowángdeyǐngxiǎng